PharmaResources (Shanghai) Co., Ltd. (SHE:301230)

China flag China · Delayed Price · Currency is CNY
37.09
+1.92 (5.46%)
At close: Jun 23, 2026
Market Cap4.84B +13.3%
Revenue (ttm)691.21M +18.5%
Net Income46.10M +81.6%
EPS0.32 +70.7%
Shares Out 137.54M
PE Ratio110.32
Forward PEn/a
Dividend0.37 (1.07%)
Ex-Dividend DateJan 13, 2026
Volume10,762,385
Open34.95
Previous Close35.17
Day's Range34.77 - 38.10
52-Week Range28.90 - 67.97
Beta0.86
Analystsn/a
Price Targetn/a
Earnings DateAug 28, 2026

About SHE:301230

PharmaResources (Shanghai) Co., Ltd. engages in new drug research, development, and commercial production in China. It offers small molecule drug CRO, CDMO, and CMO. The company also involved in drug discovery, research, and development of pharmaceutical processes; and customized and commercial production of APIs, and key intermediates. It serves global pharmaceutical and biotechnology companies. PharmaResources (Shanghai) Co., Ltd. was founded in 2007 and is based in Shanghai, China [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2007
Employees 1,155
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301230
Full Company Profile

Financial Performance

In 2025, SHE:301230's revenue was 688.35 million, an increase of 26.43% compared to the previous year's 544.47 million. Earnings were 34.29 million, an increase of 100.75%.

Financial Statements